Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

CEREGLIDE 42 Intermediate Catheter; CEREGLIDE 57 Intermediate Catheter

K-Number: K241244 · 2024-10-16

ApplicantCerenovus, Inc.
Decision Date2024-10-16
Product CodeQJP
Advisory CommitteeCV
DecisionSubstantially Equivalent

Device Summary

CEREGLIDE 42 Intermediate Catheter; CEREGLIDE 57 Intermediate Catheter is a medical device manufactured by Cerenovus, Inc.. It received FDA 510(k) clearance on 2024-10-16 under approval number K241244. The device is classified under product code QJP. It was reviewed by the CV advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the CEREGLIDE 42 Intermediate Catheter; CEREGLIDE 57 Intermediate Catheter?

CEREGLIDE 42 Intermediate Catheter; CEREGLIDE 57 Intermediate Catheter is a medical device that received FDA 510(k) clearance on 2024-10-16. It is manufactured by Cerenovus, Inc.. The 510(k) number is K241244.

When was CEREGLIDE 42 Intermediate Catheter; CEREGLIDE 57 Intermediate Catheter approved by the FDA?

CEREGLIDE 42 Intermediate Catheter; CEREGLIDE 57 Intermediate Catheter received FDA 510(k) clearance on 2024-10-16, under approval number K241244.

What company makes CEREGLIDE 42 Intermediate Catheter; CEREGLIDE 57 Intermediate Catheter?

CEREGLIDE 42 Intermediate Catheter; CEREGLIDE 57 Intermediate Catheter is manufactured by Cerenovus, Inc..

What is the FDA product code for CEREGLIDE 42 Intermediate Catheter; CEREGLIDE 57 Intermediate Catheter?

The FDA product code for CEREGLIDE 42 Intermediate Catheter; CEREGLIDE 57 Intermediate Catheter is QJP.

Related Clinical Trials

NCT02761889 Hypofractionated Image-Guided Radiotherapy (IGRT) With Organ Motion Mitigation and Urethral Sparing for Prostate Cancer COMPLETED NCT04035642 Single-Dose Image-Guided Radiotherapy With Urethral Sparing and DIL Boost for Intermediate-Risk Prostate Cancer (PROSINT II) RECRUITING NCT04790370 Ultrasound-facilitated, Catheter-directed, Thrombolysis in Intermediate-high Risk Pulmonary Embolism ACTIVE_NOT_RECRUITING NCT06453876 Percutaneous Embolectomy, Low Dose Thrombolysis or Heparin for Intermediate High Risk Pulmonary Embolism (STRATIFY II) NOT_YET_RECRUITING

Other Devices by Cerenovus, Inc.

K230726CEREGLIDE 92 Intermediate Catheter K221930CEREGLIDE 71 Intermediate Catheter K221934CEREGLIDE 71 Intermediate Catheter; Cerenovus Aspiration Tubing Set K241221CEREGLIDE 42 Intermediate Catheter; CEREGLIDE 57 Intermediate Catheter; Cerenovus Aspiration Tubing Set K233982CEREGLIDE 92 Catheter System K233988Cerenovus Large Bore Catheter; Cerenovus Aspiration Tubing Set

View all 9 devices →

Related Devices (Code: QJP)

K203043Route 92 Medical 070 Access SystemRoute 92 Medical, Inc. K201682RIST Radial Access CatheterRist Neurovascular, Inc. K201518Route 92 Medical 088 Access SystemRoute 92 Medical K201076Anchor Dual Lumen Guidewire CatheterAqure Medical, Inc. K200910BOSS Balloon Guide CatheterMarblehead Medical K200417RIST Radial Access CatheterRist Neurovascular, Inc.

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.

↑